Surgeon General Jerome Adams called on Tuesday for stricter local regulations to prevent teen vaping such as indoor bans or new taxes. His statement comes a day after research from the National Institute for Drug Abuse showed that nearly 21% of high school seniors vaped in the past month, up by nearly double from a year earlier. (USA Today)

Johnson & Johnson has started an extensive crisis communications push to contain fallout from a Reuters investigation that found that the company knew for decades that its Baby Powder contained asbestos. The company took out full-page ads in newspapers, and CEO Alex Gorsky appeared on CNBC’s Mad Money on Monday night. (Reuters)

McKesson’s Change Healthcare was in final negotiations to buy PokitDok on Friday. PokitDok is best known for applying blockchain technology to healthcare. An announcement could happen this week if both sides agree to a deal. PokitDok is backed by more than $55 million in VC money. (CNBC)

Roxadustat, an anaemia treatment from AstraZeneca and Fibrogen, has been approved by Chinese authorities, well before regulators in the U.S. or Europe could do so. The two drugmakers said they still don’t expect to launch the drug in China until the second half of next year. (Reuters) The quick approval also shows China is working to speed up its approval process (Wall Street Journal)

The FDA named Amy Abernethy, chief medical officer at Roche unit Flatiron Health, as principal deputy commissioner for food and drugs, the highest-ranking role at the organization that is not a political appointment. Roche bought Flatiron at a valuation of $2.1 billion this year. (Forbes)